Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tapentadol IR for Acute Pain Following Bunionectomy
NCT01813890Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Jan 2013
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tapentadol in acute pain, sponsored by Janssen Pharmaceutical. Started Jan 2013; status: completed.
02
Drugs
tapentadol
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT01813890.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01813890.